Wednesday, 17 June 2026

Vol. 1 · No. 15 Wednesday, 17 June 2026 “Evidence is the editor; certainty is the deadline.”

Public Health

Ebola Case Count in DRC Climbs to 808 Confirmed as Absence of BDBV Vaccine Widens Response Gap

With no licensed vaccine against the Bundibugyo strain and contact tracing reaching fewer than half of known contacts, WHO and Africa CDC are warning that the PHEIC-designated outbreak could escalate beyond any prior Ebola emergency.

James Carter, Public Health Desk · 3 min read

The World Health Organization reported 808 confirmed cases of Ebola disease caused by Bundibugyo virus (BDBV) in the Democratic Republic of the Congo as of June 14, 2026, with 192 confirmed deaths in the DRC — figures from WHO Disease Outbreak News DON607, published June 13, 2026. In Uganda, 19 confirmed cases and 2 confirmed deaths have been reported as of June 16, with no new cases recorded in Uganda since June 5, according to the same WHO update.

The DRC caseload is concentrated in Ituri Province, which accounts for 738 of the 808 DRC confirmed cases across 20 health zones. North Kivu has recorded 67 confirmed cases across 10 health zones, and South Kivu has reported 3 confirmed cases from one health zone. The outbreak is already the largest Bundibugyo virus disease outbreak on record.

Continue reading →

Also leading today

Opinion

The Bundibugyo Gap: A Warning the World's Ebola Playbook Doesn't Apply Here

The tools built after 2014 — vaccines, treatment protocols, a retooled PHEIC process — were designed for Zaire ebolavirus. This outbreak is BDBV. That is the whole problem.

The Vital Record · Editorial · 2 min

FDA & Regulatory

FDA Staff Find No Major Deficiencies in Moderna's mRNA Flu Vaccine as Panel Vote Looms

Briefing documents released June 16 signal a sharp turnaround from February's refusal-to-file letter — but approval remains weeks away, and FDA has flagged real evidence gaps.

Marcus Webb, FDA & Regulatory Desk · 3 min

In brief

Research A Single Cell Type Ages Faster in 1 in 5 People — and It Tracks Their Disease Risk A plasma proteomic study of 60,542 individuals built biological-age clocks for more than 40 cell types, finding that APOE4 homozygotes with extreme astrocyte aging face triple the incident Alzheimer's risk, and that severely aged skeletal myocytes are associated with a 12.7-fold higher ALS risk.
Digital Health & AI FDA Cleared an AI Sepsis Monitor in April; Prospective Data Show an 18.7% Relative Mortality Reduction — With Conditions Bayesian Health's TREWS platform earned 510(k) clearance April 30, 2026 — the first AI system cleared for continuous sepsis flagging in adult hospital patients. The mortality benefit applied only when clinicians confirmed the alert within three hours.

← The archive

Wednesday, 17 June 2026 edition — The Vital Record

Ebola Case Count in DRC Climbs to 808 Confirmed as Absence of BDBV Vaccine Widens Response Gap

Also leading today

The Bundibugyo Gap: A Warning the World's Ebola Playbook Doesn't Apply Here

FDA Staff Find No Major Deficiencies in Moderna's mRNA Flu Vaccine as Panel Vote Looms

In brief